image description

Tag: MD

Driving Progress in Lupus Research: Highlights from the Lupus Research Alliance 2025 Forum for Discovery 

The 2025 Lupus Research Alliance (LRA) Forum for Discovery (FFD) brought together LRA-funded investigators from around the world for its signature annual scientific meeting. Designed as a collaborative forum, the event offers a unique opportunity for researchers to share progress on their LRA-funded projects, engage in dynamic discussions with peers, and spark new collaborations that […] Read More

Lupus Research Alliance Grants Inaugural Awards to 11 Researchers Focused on Engineered Cell Therapies for Lupus

The Lupus Research Alliance (LRA) is proud to announce the inaugural recipients of the new Targeted Research Program on Engineered Cell Therapies for Lupus (TRP-ECT) to support the development and mechanistic understanding of safe and accessible next-generation engineered cell therapies for people with lupus. Engineered cell therapies, such as CD19-targeted chimeric antigen receptor (CAR) T […] Read More

Highlights from ACR Convergence 2024:  Groundbreaking LRA-Funded Research and Innovative Therapies

The Lupus Research Alliance (LRA) is proud to showcase the groundbreaking work of its funded researchers presented at the 2024 ACR Convergence meeting held this November in Washington, D.C. From novel steroid-sparing strategies to precision immunotherapies, this year’s presentations promise to bring new insights and transformative approaches to systemic lupus erythematosus (SLE) and related autoimmune […] Read More

Lupus Research Alliance Awards Lupus Insight Prize to Two Trailblazers in CAR T Cell Therapy

The Lupus Research Alliance (LRA) announced the recipients of the 2024 Lupus Insight Prize to Marko Radic, Ph.D., The University of Tennessee Health Science Center, and Georg Schett, M.D., Friedrich-Alexander-Universität Erlangen-Nürnberg, for their groundbreaking discoveries in utilizing CAR T cell therapy to potentially revolutionize lupus treatment. Drs. Radic and Schett were honored at a celebratory […] Read More

Recent Discoveries Shedding Light on Why Women Are at a Greater Risk for Lupus

Lupus is a complex autoimmune disease affecting millions worldwide with a staggering gender imbalance — about 9 of 10 people with lupus are women. Underlying biological, hormonal, or environmental factors likely contribute to why lupus affects females more often. Understanding why women are at greater risk for lupus could unlock novel treatments and revolutionize outcomes […] Read More

Overcoming the Uncertainties of Living with Chronic Diseases like Lupus

July 21, 2022 Interview with Michael D. Lockshin, MD, MACR Director Emeritus, Barbara Volcker Center for Women and Rheumatic Disease and Co-Director, Mary Kirkland Center for Lupus Research at Hospital for Special Surgery; Professor of Medicine and Obstetrics-Gynecology at Joan and Sanford Weill College of Medicine of Cornell University   Uncertainty and unpredictability are among […] Read More

Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)

  First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons NEW YORK, NY. August 2, 2021. The Lupus Research Alliance (LRA) is particularly excited about the U.S. Food and Drug Administration (FDA) approval of anifrolumab-fnia (Saphnelo™), a first-in-class type I interferon receptor antagonist indicated for adults with […] Read More

Less Risk and Greater Efficacy in Pediatric Lupus Nephritis Treatment

November 3, 2020 There is no doubt about it. The research into the mechanisms of pediatric lupus nephritis conducted by Elena Hsieh, MD, at the University of Colorado Anschutz Medical Campus, is driven by her genuine concern for the wellbeing of children—and a lifelong passion for science. With her new grant from the Lupus Research […] Read More